Gail B Kozlowski, LPN, LMT | |
5 Morgan Hwy, Suite #4, Scranton, PA 18508-2641 | |
(570) 344-3788 | |
(570) 614-0212 |
Full Name | Gail B Kozlowski |
---|---|
Gender | Female |
Speciality | Massage Therapist |
Location | 5 Morgan Hwy, Scranton, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669437679 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | PN258952L (Pennsylvania) | Secondary |
225700000X | Massage Therapist | MSG000066 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gail B Kozlowski, LPN, LMT 5 Morgan Hwy, Suite #4, Scranton, PA 18508-2641 Ph: (570) 344-3788 | Gail B Kozlowski, LPN, LMT 5 Morgan Hwy, Suite #4, Scranton, PA 18508-2641 Ph: (570) 344-3788 |
News Archive
New research strongly suggests that a mix of preventative agents, such as those found in concentrated black raspberries, may more effectively inhibit cancer development than single agents aimed at shutting down a particular gene.
Almost four million people die each year from household air pollution (HAP) caused by exposure to the combustion of biomass fuels (wood, charcoal, crop residues, and dung), kerosene, or coal.
BioMedTracker, a product of Sagient Research Systems, the leading provider of competitive intelligence and investment analytics on the biotech/pharmaceutical sector, today announced the recent launch of its new service, Thought Leader Opinions (TLO). This service provides its subscribers with direct access to the latest expert opinions in the disease areas that they follow within the intuitive BioMedTracker drug information platform.
Tulane University's Stryder Meadows, a cell and molecular biology professor, received a $1.7 million grant from the Department of Defense to study how arteriovenous malformations (AVM), which are defects in arteries, veins and capillaries, form Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects about 1 in 5,000 people.
› Verified 5 days ago